Fetal and Neonatal Monitoring Devices Market Report 2025

This Fetal and Neonatal Monitoring Devices market report provides a comprehensive analysis of the market’s characteristics, size, and growth, including segmentation, regional and country-level breakdowns, competitive landscape, market shares, trends, and strategies. It also tracks historical and forecasted market growth across various geographies.

The fetal and neonatal monitoring devices market size has grown strongly in recent years. It will grow from $9.47 billion in 2024 to $10.25 billion in 2025 at a compound annual growth rate (CAGR) of 8.2%. The growth in the historic period can be attributed to maternal and neonatal health awareness, healthcare access, high-risk pregnancies, emerging markets growth.

The fetal and neonatal monitoring devices market size is expected to see strong growth in the next few years. It will grow to $13.42 billion in 2029 at a compound annual growth rate (CAGR) of 7%. The growth in the forecast period can be attributed to telemedicine and remote monitoring, personalized medicine, increased premature birth rates, value-based healthcare. Major trends in the forecast period include non-invasive monitoring, wearable and home monitoring devices, artificial intelligence (ai) and machine learning, data security and privacy.

The rising incidence of preterm births and low birth weight infants is a key factor driving the growth of the fetal and neonatal monitoring devices market. Preterm birth refers to the early delivery of a baby before 37 weeks of gestation, which can lead to various health issues, including developmental delays, mental retardation, visual and hearing impairments, and cerebral palsy. Fetal and neonatal monitoring devices are crucial for managing preterm births and low birth weight infants by continuously monitoring vital signs and health parameters. These devices help detect complications early and enable timely medical intervention, improving survival rates and long-term health outcomes. For example, in May 2024, the Office for National Statistics, a UK-based authority, reported that the proportion of preterm live births increased from 7.5% in 2021 to 7.9% in 2022. Therefore, the rising prevalence of preterm births and low birth weight is driving the growth of the fetal and neonatal monitoring devices market.

The growth in healthcare expenditure is expected to drive the expansion of the fetal and neonatal monitoring devices market. Healthcare expenditure includes the total money spent on healthcare goods and services, such as medical equipment, hospital services, physician services, prescription drugs, and public health activities. Increased healthcare spending directly impacts the quality of maternal and neonatal care by providing the resources needed for the development, deployment, and use of advanced fetal and neonatal monitoring devices. For example, in November 2023, the Canadian Institute for Health Information, a Canadian non-profit organization, forecasted that total health spending in Canada would rise by 2.8% in 2023, following a modest increase of just 1.5% in 2022. Thus, growing healthcare expenditure is fueling the growth of the fetal and neonatal monitoring devices market.

Leading companies in the fatty acid market are placing a strong emphasis on innovation by introducing cutting-edge devices like the Neonatal Care Warmer Babyroo TN300 to strengthen their market positions. The Neonatal Care Warmer, also known as an infant radiant warmer, is a medical apparatus designed to create a controlled and warm environment for newborn infants, especially those born prematurely or with specific medical needs. In a notable development, Dräger, a German-based company renowned for its gas detection and analysis systems, as well as respiratory and protective equipment, unveiled the Neonatal Care Warmer Babyroo TN300 in June 2023. The Babyroo TN300 represents a significant advancement in newborn care within labor and delivery rooms, as well as Neonatal Intensive Care Units (NICUs). This open-care warmer is equipped with resuscitation tools and offers a customizable design with state-of-the-art thermoregulation capabilities. The pre-warming function ensures that the mattress is prepared at the optimal temperature for newborns, underscoring the product's commitment to providing a secure and comfortable environment for these infants.

Manufacturers of fetal and neonatal monitoring devices are increasingly focusing on innovation and the integration of cutting-edge technologies, including wireless technology, into patient monitoring devices. This integration aims to enhance the diagnosis and monitoring of fetuses and newborns with greater efficiency. Among these innovative technologies, wireless sensor technology plays a crucial role, encompassing biosensor monitoring devices and wireless fetal heart rate monitoring devices. These wireless sensor systems are either implanted or embedded into the patient's skin, equipped with sensors that transmit real-time medical data for monitoring the patient's condition. For example, the National Institute of Neurological Disorders and Stroke has developed SARA, a scanning device capable of detecting fetal brain activity using flashes of light transmitted through the mother's abdomen. Similarly, Philips has introduced a cordless fetal monitoring device designed to ensure the safety of both the mother and child without any inconvenience or risk. These technological advancements address issues related to poor signal reception during observation and enable healthcare providers to monitor patients more efficiently and effectively.

In July 2022, ArchiMed Group, a France-based investment firm, acquired Natus Medical Incorporated for $1.2 billion. This acquisition enables ArchiMed to incorporate Natus's existing product portfolio, which includes advanced monitoring systems for neonatal care, such as the Olympic Brainz Monitor. Natus Medical Incorporated, a US-based company, provides medical device solutions for diagnosing and treating disorders that impact the brain and sensory systems of newborns.

Fetal and neonatal monitoring devices play a crucial role in assessing the health of both expectant mothers and newborns. These devices are employed to monitor vital parameters during pregnancy and childbirth, ensuring the well-being of both the fetus and neonate.

The equipment in the fetal and neonatal monitoring devices and equipment category can be categorized as either fetal or neonatal monitoring tools. Fetal monitoring equipment includes ultrasound devices, fetal dopplers, fetal MRI systems, fetal monitors, and fetal pulse oximeters. On the other hand, neonatal monitoring equipment encompasses infant warmers, incubators, convertible warmers, incubators, phototherapy equipment, respiratory devices, neonatal monitoring devices, and diagnostic imaging devices. These monitoring devices are utilized by various healthcare facilities, including hospitals, diagnostic centers, pediatric clinics, and ambulatory surgical centers, to ensure the health and safety of pregnant women and newborns throughout the childbirth process.

The fetal and neonatal monitoring devices and equipment market research report is one of a series of new reports that provides fetal and neonatal monitoring devices and equipment market statistics, including fetal and neonatal monitoring devices and equipment industry global market size, regional shares, competitors with a fetal and neonatal monitoring devices and equipment market share, detailed fetal and neonatal monitoring devices and equipment market segments, market trends and opportunities, and any further data you may need to thrive in the fetal and neonatal monitoring devices and equipment industry. This fetal and neonatal monitoring devices and equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Major companies operating in the fetal and neonatal monitoring devices market include GE Healthcare, Fisher & Paykel Healthcare Limited, Philips Healthcare, Atom Medical Corporation, Natus Medical Incorporated, Analogic Corporation, Phoenix Medical Systems (P) Ltd., Becton Dickinson and Company, Masimo Corporation, Drägerwerk AG & Co. KGAA, CareFusion Corporation, Nonin Medical, Koninklijke Philips N.V., Welch Allyn Inc., Spacelabs Healthcare, Smiths Medical Inc., Getinge AB, FUJIFILM SonoSite Inc., Siemens Healthcare GMBH, Incereb Ltd., Utah Medical Products Inc., OSI Systems, Lutech Industries Inc., Neoventa Medical AB, CardiacDirect, International Biomedical Ltd., Medtronic Plc, Abbott Laboratories, Hill-Rom, Edwards Lifesciences, OMRON, Shenzhen Mindray Bio-Medical Electronics Co. Ltd., CooperSurgical Inc., Huntleigh Healthcare Limited, Nihon Kohden Corporation, Arjohuntleigh Healthcare India Private Limited, Advanced Instrumentations, Dixion Vertrieb medizinischer Geräte GmbH, Mediana Co. Ltd., NCC Medical Co. Ltd.

Asia-Pacific was the largest region in the global fetal and neonatal monitoring devices and equipment market in 2024. North America was the second-largest region in the fetal and neonatal monitoring devices and equipment market. The regions covered in the fetal and neonatal monitoring devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the fetal and neonatal monitoring devices market report are Australia, China, India, Indonesia, Japan, South Korea, Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, USA, Canada, Mexico, Brazil, Chile, Argentina, Colombia, Peru, France, Germany, UK, Austria, Belgium, Denmark, Finland, Ireland, Italy, Netherlands, Norway, Portugal, Spain, Sweden, Switzerland, Russia, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.

The fetal and neonatal monitoring devices market consists of sales of instruments such as ultrasound devices, fetal dopplers, fetal MRI systems, fetal monitors, and fetal pulse oximeters. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.